menu
    • menu

    Company profile for Merrimack Pharmaceuticals

    NEW Drugs in Dev.: 9
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. The Company does not...
    Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. The Company does not have any employees and instead uses external consultants for the operation of the Company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Merrimack PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Broadway, 14th floor Cambridge, MA 02142
    Telephone
    Telephone
    617-720-8606
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.merrimack.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/merrimack-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merrimack Dissolution, $15.10 Liquidating Dividend Approved
    Merrimack Dissolution, $15.10 Liquidating Dividend Approved

    10 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240510857372/en

    BUSINESSWIRE
    10 May 2024
    Share Share
    Merrimack Anticipated Liquidation Distribution Amount
    Merrimack Anticipated Liquidation Distribution Amount

    09 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240509655112/en

    BUSINESSWIRE
    09 May 2024
    Share Share
    Merrimack to Voluntarily Delist, Subject to Dissolution Approval
    Merrimack to Voluntarily Delist, Subject to Dissolution Approval

    30 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240430653360/en

    BUSINESSWIRE
    30 Apr 2024
    Share Share
    Merrimack Receives $225 Million Milestone Payment from Ipsen
    Merrimack Receives $225 Million Milestone Payment from Ipsen

    27 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240327941499/en

    BUSINESSWIRE
    27 Mar 2024
    Share Share
    Merrimack Reports Full Year 2023 Financial Results
    Merrimack Reports Full Year 2023 Financial Results

    07 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240307337790/en

    BUSINESSWIRE
    07 Mar 2024
    Share Share
    Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
    Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

    14 Feb 2024

    // PRESS RELEASE

    https://investors.merrimack.com/news-releases/news-release-details/merrimack-reports-ipsen-announcement-approval-us-fda-onivyder

    PRESS RELEASE
    14 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search